Prasco Laboratories
- A02 - Agentes para el tratamiento de alteraciones causadas por ácidos
- OMEPRAZOLE SODIUM BICARBONATE PRASCO capsule, hard 20 mg+1 100 mg
- OMEPRAZOLE SODIUM BICARBONATE PRASCO capsule, hard 40 mg+1 100 mg
- A05 - Terapia biliar y hepática
- URSODIOL PRASCO film-coated tablet 250 mg
- URSODIOL PRASCO film-coated tablet 500 mg
- A07 - Antidiarreicos, antiinfecciosos y antiinflamatorios intestinales
- MESALAMINE PRASCO prolonged-release capsule, hard 250 mg
- MESALAMINE PRASCO prolonged-release capsule, hard 500 mg
- B02 - Antihemorrágicos
- TRANEXAMIC ACID PRASCO tablet 650 mg
- G03 - Hormonas sexuales y moduladores del sistema genital
- TESTOSTERONE PRASCO gel 1%
- H05 - Homeostasis del calcio
- DOXERCALCIFEROL PRASCO capsule, soft 0.5 µg
- DOXERCALCIFEROL PRASCO capsule, soft 1 µg
- DOXERCALCIFEROL PRASCO capsule, soft 2.5 µg
- J01 - Antibacterianos para uso sistémico
- VANCOMYCIN HYDROCHLORIDE PRASCO capsule, hard 125 mg
- VANCOMYCIN HYDROCHLORIDE PRASCO capsule, hard 250 mg
- N03 - Antiepilépticos
- CARBAMAZEPINE PRASCO prolonged-release capsule, hard 100 mg
- CARBAMAZEPINE PRASCO prolonged-release capsule, hard 200 mg
- CARBAMAZEPINE PRASCO prolonged-release capsule, hard 300 mg
- P01 - Antiprotozoarios
- ATOVAQUONE PRASCO oral suspension 750 mg/5 ml
- ATOVAQUONE PROGUANIL HCL PRASCO film-coated tablet 100 mg+250 mg
- HYDROXYCHLOROQUINE SULFATE PRASCO tablet 200 mg
- S01 - Oftalmológicos
- DORZOLAMIDE HCL PRASCO eye drops, solution 2%
- DORZOLAMIDE HYDROCHLORIDE TIMOLOL MALEATE PRASCO eye drops, solution 0.5%+2%